Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
Phase 2
Not yet recruiting
- Conditions
- Asthma
- Interventions
- Other: Glycerin with Oxyquinoline SulfateDrug: Antipyrine-benzocaine otic solution
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Global United Pharmaceutical Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT02153541
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath